RESPIRATORY TRACT NEOPLASMS
Clinical trials for RESPIRATORY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for RESPIRATORY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingThis study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutated non-small cell lung cancer. About 532 adults with stage IIIB, IIIC, or IV lung cancer that cannot be surgically removed are being observ…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
Last-Resort drug access opens for rare lung cancer patients
Disease control NO_LONGER_AVAILABLEThis program offers taletrectinib to adults with advanced or spreading ROS1-positive non-small cell lung cancer who cannot use approved treatments or join ongoing studies. Participants must have a ROS1 gene fusion and adequate organ function. The goal is to provide potential bene…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 17, 2026 02:44 UTC
-
Can doctor training boost lung cancer treatment in smaller hospitals?
Knowledge-focused OngoingThis study looks at whether educating doctors in smaller city and county hospitals can improve how they test and treat patients with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more patients get the right molecular tests and targeted therap…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 02:56 UTC